Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2025-12-25 @ 11:18 PM
Study NCT ID:
NCT04546893
Status:
UNKNOWN
Last Update Posted:
2020-09-14
First Post:
2020-09-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of SL1904B CAR-T Cells for Relapsed or Refractory B-Cell Acute Lymphocyte Leukemia
Sponsor:
Hebei Senlang Biotechnology Inc., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-04
First Submit QC Date:
None
Study First Post Date:
2020-09-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-04
Last Update Post Date:
2020-09-14
Last Update Post Date Type:
ACTUAL